Literature DB >> 22367170

Adult patients with sporadic polycystic kidney disease: the importance of screening for mutations in the PKD1 and PKD2 genes.

Hartmut P H Neumann1, Janina Bacher, Zinaida Nabulsi, Nadine Ortiz Brüchle, Michael M Hoffmann, Elke Schaeffner, Jens Nürnberger, Markus Cybulla, Jochen Wilpert, Peter Riegler, Robert Corradini, Annette Kraemer-Guth, Pablo Azurmendi, Mercedes Nunez, Sven Gläsker, Klaus Zerres, Cordula Jilg.   

Abstract

BACKGROUND: ADPKD is one of the most common inherited disorders, with high risk for end-stage renal disease. Numerous patients, however, have no relatives in whom this disorder is known and are unsure whether they may transmit the disease to their offsprings. The aim of this study was to evaluate whether germline mutation analysis adds substantial information to clinical symptoms for diagnosis of ADPKD in these patients.
METHODS: Clinical data included renal function and presence of liver or pancreas cysts, heart valve insufficiency, intracranial aneurysms, colonic diverticles, and abdominal hernias. Family history was evaluated regarding ADPKD. Germline mutation screening of the PKD1 and PKD2 genes was performed for intragenic mutations and for large deletions.
RESULTS: A total of 324 adult patients with ADPKD including 30 patients without a family history of ADPKD (sporadic cases) were included. PKD1 mutations were found in 24/30 and PKD2 mutations in 6 patients. Liver cysts were present in 14 patients and intracranial aneurysms in 2 patients. Fourteen patients (45%) had no extrarenal involvement. Compared to the 294 patients with familial ADPKD, the clinical characteristics and the age at the start of dialysis were similar in those with sporadic ADPKD.
CONCLUSION: The clinical characteristics of patients with sporadic and familial ADPKD are similar, but sporadic ADPKD is often overlooked because of the absence of a family history. Molecular genetic screening for germline mutations in both PKD1 and PKD2 genes is essential for the definitive diagnosis of ADPKD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22367170     DOI: 10.1007/s11255-012-0125-0

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  16 in total

1.  Von Hippel-Lindau disease masquerading as autosomal dominant polycystic kidney disease.

Authors:  R K Chatha; A M Johnson; P G Rothberg; R R Townsend; H P Neumann; P A Gabow
Journal:  Am J Kidney Dis       Date:  2001-04       Impact factor: 8.860

Review 2.  Polycystic kidney disease.

Authors:  Patricia D Wilson
Journal:  N Engl J Med       Date:  2004-01-08       Impact factor: 91.245

Review 3.  Autosomal dominant polycystic kidney disease.

Authors:  Vicente E Torres; Peter C Harris; Yves Pirson
Journal:  Lancet       Date:  2007-04-14       Impact factor: 79.321

4.  PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein.

Authors:  T Mochizuki; G Wu; T Hayashi; S L Xenophontos; B Veldhuisen; J J Saris; D M Reynolds; Y Cai; P A Gabow; A Pierides; W J Kimberling; M H Breuning; C C Deltas; D J Peters; S Somlo
Journal:  Science       Date:  1996-05-31       Impact factor: 47.728

Review 5.  Extrarenal manifestations of autosomal dominant polycystic kidney disease.

Authors:  Yves Pirson
Journal:  Adv Chronic Kidney Dis       Date:  2010-03       Impact factor: 3.620

Review 6.  Autosomal dominant polycystic kidney disease.

Authors:  P A Gabow
Journal:  N Engl J Med       Date:  1993-07-29       Impact factor: 91.245

7.  Familial phenotype differences in PKD11.

Authors:  N Hateboer; L P Lazarou; A J Williams; P Holmans; D Ravine
Journal:  Kidney Int       Date:  1999-07       Impact factor: 10.612

8.  The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease.

Authors:  Sandro Rossetti; Sarah Burton; Lana Strmecki; Gregory R Pond; Jośe L San Millán; Klaus Zerres; T Martin Barratt; Seza Ozen; Vicente E Torres; Erik J Bergstralh; Christopher G Winearls; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

9.  Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype.

Authors:  Sandro Rossetti; Dominique Chauveau; Vickie Kubly; Jeffrey M Slezak; Anand K Saggar-Malik; York Pei; Albert C M Ong; Fiona Stewart; Michael L Watson; Erik J Bergstralh; Christopher G Winearls; Vicente E Torres; Peter C Harris
Journal:  Lancet       Date:  2003-06-28       Impact factor: 79.321

10.  The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. The European Polycystic Kidney Disease Consortium.

Authors: 
Journal:  Cell       Date:  1994-08-26       Impact factor: 41.582

View more
  8 in total

1.  Identification of PKD1 and PKD2 gene variants in a cohort of 125 Asian Indian patients of ADPKD.

Authors:  Shewata Pandita; Vijaya Ramachandran; Prahlad Balakrishnan; Arndt Rolfs; Oliver Brandau; Sabrina Eichler; Anil Kumar Bhalla; Dinesh Khullar; Vindu Amitabh; Sivaramakrishnan Ramanarayanan; Vijay Kher; Jyotsna Verma; Sudha Kohli; Renu Saxena; Ishwar Chander Verma
Journal:  J Hum Genet       Date:  2019-02-28       Impact factor: 3.172

2.  Mutational screening of PKD2 gene in the north Indian polycystic kidney disease patients revealed 28 genetic variations.

Authors:  Sonam Raj; Rana Gopal Singh; Parimal Das
Journal:  J Genet       Date:  2017-12       Impact factor: 1.166

3.  Identification of a pathogenic mutation in a Chinese pedigree with polycystic kidney disease.

Authors:  Kexian Dong; Huanhuan Miao; Xueyuan Jia; Jie Wu; Han Wu; Jiawei Sun; Wei Ji; Hui Su; Lidan Xu; Xuelong Zhang; Siqi Zhu; Guohua Ji; Rongwei Guan; Hao Wang; Jing Bai; Jingcui Yu; Wenjing Sun; Xianli Zhou; Songbin Fu
Journal:  Mol Med Rep       Date:  2019-01-31       Impact factor: 2.952

4.  Isolated hypoglossal nerve palsy from internal carotid artery dissection related to PKD-1 gene mutation.

Authors:  Zhaoyao Chen; Jun Yuan; Hui Li; Cuiping Yuan; Kailin Yin; Sen Liang; Pengfei Li; Minghua Wu
Journal:  BMC Neurol       Date:  2019-11-08       Impact factor: 2.474

5.  Characteristics of intracranial aneurysms in the else kröner-fresenius registry of autosomal dominant polycystic kidney disease.

Authors:  Hartmut P H Neumann; Angelica Malinoc; Janina Bacher; Zinaida Nabulsi; Vera Ivanovas; Nadine Ortiz Bruechle; Irina Mader; Michael M Hoffmann; Peter Riegler; Annette Kraemer-Guth; Christian Burchardi; Elke Schaeffner; Rodolfo S Martin; Pablo J Azurmendi; Klaus Zerres; Cordula Jilg; Charis Eng; Sven Gläsker
Journal:  Cerebrovasc Dis Extra       Date:  2012-10-09

6.  Identification of novel PKD1 and PKD2 mutations in a Chinese population with autosomal dominant polycystic kidney disease.

Authors:  Bei Liu; Song-Chang Chen; Yan-Mei Yang; Kai Yan; Ye-Qing Qian; Jun-Yu Zhang; Yu-Ting Hu; Min-Yue Dong; Fan Jin; He-Feng Huang; Chen-Ming Xu
Journal:  Sci Rep       Date:  2015-12-03       Impact factor: 4.379

7.  Novel mutations of PKD genes in the Czech population with autosomal dominant polycystic kidney disease.

Authors:  Lena Obeidova; Veronika Elisakova; Jitka Stekrova; Jana Reiterova; Miroslav Merta; Vladimir Tesar; Frantisek Losan; Milada Kohoutova
Journal:  BMC Med Genet       Date:  2014-04-03       Impact factor: 2.103

8.  Novel mutations of PKD genes in Chinese patients suffering from autosomal dominant polycystic kidney disease and seeking assisted reproduction.

Authors:  Wen-Bin He; Wen-Juan Xiao; Yue-Qiu Tan; Xiao-Meng Zhao; Wen Li; Qian-Jun Zhang; Chang-Gao Zhong; Xiu-Rong Li; Liang Hu; Guang-Xiu Lu; Ge Lin; Juan Du
Journal:  BMC Med Genet       Date:  2018-10-17       Impact factor: 2.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.